Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

151 recalls · Class I, newest first

Class I · High risk

Betaxolol Tablets

Presence of Foreign Tablets/Capsules: There is a potential presence of oxycodone HCl tablets, USP 5 mg in bottles.

Terminated Particulate / foreign matter KVK-Tech, Inc. NDC 10702-013-01 D-0049-2024
Class I · High risk

Sodium Acetate Injection

Presence of particulate matter: particulates composed of carbon and oxygen with varying amounts of iron and trace amounts of sodium, silicon, chromium, aluminum and cellulose.

Terminated Particulate / foreign matter Fresenius Kabi USA, LLC NDC 63323-032-00 D-0750-2022
Class I · High risk

Veklury (remdesivir)

Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.

Terminated Particulate / foreign matter Gilead Sciences, Inc. NDC 61958-2901-2 D-0299-2022
Class I · High risk

Topotecan Injection 4 mg/4mL

Presence of Particulate Matter: Complaint received of a glass particle observed inside the vial. The vial was returned to Teva for further analysis where two other particulates were found and identified as one (1) grey silicone particle and one (1) translucent, colorless cotton fiber.

Terminated Particulate / foreign matter Teva Pharmaceuticals USA NDC 0703-4714-01 D-0661-2021
Class I · High risk

Ketorolac Trom

Presence of Particulate Matter: Medication relabeled at facility was recalled by the manufacturer due to small black particles noticed during routine visual inspection. of retain samples.

Terminated Particulate / foreign matter RemedyRepack Inc. NDC 70518-1239-00 D-0867-2020

Recalls by year